VJHemOnc is committed to improving our service to you

iwNHL 2015 | Emerging monoclonal antibodies for lymphoma therapy

VJHemOnc is committed to improving our service to you

Thomas Kipps

At the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2015 meeting, Thomas J. Kipps, MD, PhD, of the University of California, San Diego, San Diego, CA, discusses novel monoclonal antibodies against CD20, including rituximab, ofatumumab and obinutuzumab, that are progressing in clinical development as single agents and in combination for the treatment of patients with non-Hodgkin lymphoma.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter